Biotechnology - , ,
Sideromics is a pharmaceutical company engaged in Research and Development of novel compounds and methods to treat and prevent diseases and disorders caused by pathogenic microorganisms, such as bacteria, fungi, and parasites. Through innovative chemistry and proprietary formulations, Sideromics has developed a pipeline of products around our SIDEROCILLIN™ platform. Our intellectual property continues to grow along with a variety of indications in humans and animals. The SIDEROCILLIN™ line of products ranges from early proof of concept, through advanced stages of development. Our current and pending patents and IP cover a broad range of applications in the United States and globally. SIDEROCILLIN™ compounds are being formulated for intravenous, mucosal, oral, and topical administration.
DoubleClick
Outlook
Wix
Facebook Login (Connect)
YouTube
Mobile Friendly